Nektar Therapeutics
NKTR
$0.8968
$0.08149.98%
09/30/2024 | 06/30/2024 | ||||
---|---|---|---|---|---|
Revenue | 2.70% | 8.55% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 2.70% | 8.55% | |||
Cost of Revenue | -54.47% | 14.13% | |||
Gross Profit | 43.20% | 4.91% | |||
SG&A Expenses | -7.57% | 1.79% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -2.59% | 6.92% | |||
Operating Income | 5.99% | -5.90% | |||
Income Before Tax | 29.19% | -42.02% | |||
Income Tax Expenses | -80.43% | 231.43% | |||
Earnings from Continuing Operations | 29.23% | -42.28% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 29.23% | -42.28% | |||
EBIT | 5.99% | -5.90% | |||
EBITDA | 4.91% | -6.64% | |||
EPS Basic | 29.36% | -32.65% | |||
Normalized Basic EPS | 5.39% | -1.48% | |||
EPS Diluted | 29.36% | -32.65% | |||
Normalized Diluted EPS | 5.39% | -1.48% | |||
Average Basic Shares Outstanding | 0.20% | 7.23% | |||
Average Diluted Shares Outstanding | 0.20% | 7.23% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |